Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

US Patent 8921368 · Granted Dec 30, 2014

Estimated economic value: $242,906,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic heterocyclic compounds useful as IRAK4 inhibitors2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
PRMT5 inhibiting compounds and uses thereof2025
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4 inhibitors2025
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4 inhibitors2025
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors2025
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors2025
Indazole carboxamides as kinase inhibitors2025
Amide-substituted heterocyclic compounds for the treatment of conditions related2025
Display substrate having a blocking dam provided with at least one groove and ma2025